slotkoers
Shenzhen S.E.
00:00:00 30-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
18,82
CNY
|
+9,55%
|
|
+13,99%
|
+12,97%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
5.367
|
7.742
|
7.390
|
11.167
|
8.741
|
6.336
|
Bedrijfswaarde
1 |
5.161
|
7.372
|
6.903
|
10.838
|
8.533
|
5.866
|
K/w-verhouding
|
20,4
x
|
38,2
x
|
-15,1
x
|
104
x
|
32,1
x
|
37
x
|
Dividendrendement
|
1,83%
|
1,01%
|
1,06%
|
0,68%
|
0,66%
|
1,2%
|
Marktkapitalisatie/omzet
|
1,78
x
|
2,77
x
|
2,49
x
|
3,56
x
|
2,49
x
|
1,79
x
|
Bedrijfswaarde/omzet
|
1,72
x
|
2,64
x
|
2,33
x
|
3,45
x
|
2,43
x
|
1,66
x
|
Bedrijfswaarde/EBITDA
|
8
x
|
12,1
x
|
13,1
x
|
24,5
x
|
13,7
x
|
11,2
x
|
Bedrijfswaarde/FCF
|
-3.242
x
|
31,6
x
|
28,7
x
|
1.121
x
|
74
x
|
23,3
x
|
FCF Yield
|
-0,03%
|
3,16%
|
3,48%
|
0,09%
|
1,35%
|
4,28%
|
Price to Book
|
1,34
x
|
1,9
x
|
2,15
x
|
3,29
x
|
2,42
x
|
1,72
x
|
Aantal aandelen (in duizenden)
|
393.152
|
390.026
|
387.903
|
383.875
|
383.875
|
380.338
|
Referentieprijs
2 |
13,65
|
19,85
|
19,05
|
29,09
|
22,77
|
16,66
|
Datum van publicatie
|
28/03/19
|
20/04/20
|
26/04/21
|
24/03/22
|
30/03/23
|
28/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
3.008
|
2.795
|
2.962
|
3.138
|
3.506
|
3.538
|
EBITDA
1 |
645,1
|
608,3
|
526,7
|
443,2
|
624,7
|
525,4
|
Bedrijfsresultaat (EBIT)
1 |
475,7
|
429,2
|
328,7
|
224
|
373,3
|
220
|
Operationele Marge
|
15,81%
|
15,36%
|
11,1%
|
7,14%
|
10,65%
|
6,22%
|
Resultaat voor belastingen (EBT)
1 |
370,1
|
315,2
|
-425,4
|
196,6
|
346
|
225,4
|
Nettowinst (verlies)
1 |
263,9
|
203,3
|
-488,8
|
108
|
273,4
|
174,7
|
Nettomarge
|
8,77%
|
7,27%
|
-16,5%
|
3,44%
|
7,8%
|
4,94%
|
WPA
2 |
0,6700
|
0,5200
|
-1,260
|
0,2800
|
0,7100
|
0,4500
|
Free Cash Flow
1 |
-1,592
|
233,2
|
240,6
|
9,671
|
115,3
|
251,2
|
FCF-marge
|
-0,05%
|
8,34%
|
8,12%
|
0,31%
|
3,29%
|
7,1%
|
Kasstroomconversie (ebitda)
|
-
|
38,34%
|
45,67%
|
2,18%
|
18,46%
|
47,81%
|
Kasstroomconversie (nettowinst)
|
-
|
114,73%
|
-
|
8,96%
|
42,19%
|
143,79%
|
Dividend per aandeel
2 |
0,2500
|
0,2000
|
0,2018
|
0,1982
|
0,1500
|
0,2000
|
Datum van publicatie
|
28/03/19
|
20/04/20
|
26/04/21
|
24/03/22
|
30/03/23
|
28/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
205
|
370
|
487
|
329
|
208
|
471
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-1,59
|
233
|
241
|
9,67
|
115
|
251
|
ROE (netto-inkomsten/eigen vermogen)
|
7,04%
|
5,24%
|
-12,7%
|
3,56%
|
8,05%
|
5,2%
|
ROA (netto-inkomsten/totale activa)
|
5,83%
|
4,93%
|
3,88%
|
2,72%
|
4,2%
|
2,34%
|
Totale activa
1 |
4.522
|
4.123
|
-12.604
|
3.963
|
6.503
|
7.461
|
Nettoactief per aandeel
2 |
10,20
|
10,40
|
8,870
|
8,840
|
9,420
|
9,680
|
Cashflow per aandeel
2 |
1,840
|
2,540
|
2,780
|
2,560
|
2,240
|
2,670
|
Capex
1 |
350
|
362
|
272
|
376
|
374
|
343
|
Capex/omzet
|
11,63%
|
12,94%
|
9,2%
|
11,99%
|
10,66%
|
9,69%
|
Datum van publicatie
|
28/03/19
|
20/04/20
|
26/04/21
|
24/03/22
|
30/03/23
|
28/03/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| +12,97% | 986 mln. | | +21,85% | 546 mld. | | -4,77% | 359 mld. | | +16,97% | 323 mld. | | +5,69% | 290 mld. | | +13,68% | 234 mld. | | +3,65% | 198 mld. | | -11,12% | 194 mld. | | +8,08% | 167 mld. | | -3,40% | 157 mld. |
Farmaceutische producten - Andere
|